Results for "Red Light Therapy" in Alzheimer's

20 articles

Light Therapy Device Tested Against Long COVID Brain Fog in Remote RCT
Brain Health

Light Therapy Device Tested Against Long COVID Brain Fog in Remote RCT

A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.

Clinical Trial
Jun 3, 2026 0
Light Therapy Shows Promise for Sleep and Memory in Alzheimer's and Cognitive Decline
Brain Health

Light Therapy Shows Promise for Sleep and Memory in Alzheimer's and Cognitive Decline

Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.

Clinical Trial
Mar 28, 2026 2
Psilocybin Plus Mindfulness Shows Promise for Healthcare Worker Burnout and Depression
Brain Health

Psilocybin Plus Mindfulness Shows Promise for Healthcare Worker Burnout and Depression

Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.

Clinical Trial
Mar 29, 2026 0
Psilocybin Plus Therapy Shows Promise for Depression in Completed Clinical Trial
Brain Health

Psilocybin Plus Therapy Shows Promise for Depression in Completed Clinical Trial

60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.

Clinical Trial
Mar 28, 2026 0
CBT Smartphone App Tested Against Active Placebo for Moderate Depression
Brain Health

CBT Smartphone App Tested Against Active Placebo for Moderate Depression

A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.

Clinical Trial
May 9, 2026 0
LSD Shows Promise for Treating Anxiety in Life-Threatening Illness Study
Brain Health

LSD Shows Promise for Treating Anxiety in Life-Threatening Illness Study

Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.

Clinical Trial
Mar 28, 2026 1
Microdosing Psilocybin Shows Promise for Major Depression in Clinical Trial
Brain Health

Microdosing Psilocybin Shows Promise for Major Depression in Clinical Trial

Small doses of psilocybin tested against placebo in 39 adults with major depressive disorder to assess safety and mood benefits.

Clinical Trial
Mar 29, 2026 0
Psilocybin Shows Promise for Treatment-Resistant Depression in Clinical Trial
Brain Health

Psilocybin Shows Promise for Treatment-Resistant Depression in Clinical Trial

Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.

Clinical Trial
Mar 28, 2026 1
Mindfulness Training Reduces Menopause Symptoms in BRCA Carriers After Surgery
Brain Health

Mindfulness Training Reduces Menopause Symptoms in BRCA Carriers After Surgery

Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.

Clinical Trial
Mar 28, 2026 0
Digital Brain Training Program Shows Promise for Healthy Aging in Older Adults
Brain Health

Digital Brain Training Program Shows Promise for Healthy Aging in Older Adults

German researchers test whether digital environmental enrichment can boost mental and physical wellbeing in seniors through telehealth.

Clinical Trial
Mar 28, 2026 1
Psilocybin Therapy Shows Promise for End-of-Life Psychological Distress
Brain Health

Psilocybin Therapy Shows Promise for End-of-Life Psychological Distress

Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.

Clinical Trial
Mar 28, 2026 1
SSRI Antidepressants May Block Psychedelic Effects by Reducing Brain Receptors
Brain Health

SSRI Antidepressants May Block Psychedelic Effects by Reducing Brain Receptors

Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.

Clinical Trial
Mar 28, 2026 1
Phase 3 Trial Zeros In on Optimal EPO Dose and Timing for Traumatic Optic Nerve Injury
Brain Health

Phase 3 Trial Zeros In on Optimal EPO Dose and Timing for Traumatic Optic Nerve Injury

TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.

Clinical Trial
Jun 9, 2026 0
Psilocybin Shows Promise for Anorexia Nervosa in Small Clinical Trial
Brain Health

Psilocybin Shows Promise for Anorexia Nervosa in Small Clinical Trial

UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.

Clinical Trial
Mar 28, 2026 1
Mobile App Trial in Older HIV Patients: A Pilot RCT in Spain
Brain Health

Mobile App Trial in Older HIV Patients: A Pilot RCT in Spain

A pilot RCT tested whether a smartphone app could improve quality of life and treatment adherence in HIV-positive patients aged 60+.

Clinical Trial
May 19, 2026 0
CBT-I Therapy Targets Both Sleep and Alzheimer's Amyloid in Older Adults
Brain Health

CBT-I Therapy Targets Both Sleep and Alzheimer's Amyloid in Older Adults

A completed RCT tests whether treating insomnia with CBT-I can improve cognition and slow amyloid buildup in adults aged 60โ€“85.

Clinical Trial
May 14, 2026 0
Hyperbaric Oxygen Therapy Targets Cognition in Diabetic Elderly at Dementia Risk
Brain Health

Hyperbaric Oxygen Therapy Targets Cognition in Diabetic Elderly at Dementia Risk

A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.

Clinical Trial
Jun 18, 2026 0
Psilocybin Shows Promise for Alcohol Addiction and Depression Treatment
Brain Health

Psilocybin Shows Promise for Alcohol Addiction and Depression Treatment

French pilot study tests psychedelic therapy for patients with alcohol use disorder and comorbid depression after withdrawal.

Clinical Trial
Mar 29, 2026 0
Single vs Double Bevacizumab Injections Compared for Macular Degeneration Treatment
Brain Health

Single vs Double Bevacizumab Injections Compared for Macular Degeneration Treatment

A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.

Clinical Trial
May 8, 2026 0
Yale Psilocybin Trial for Post-Concussion Headaches Shows Promise Despite Early End
Brain Health

Yale Psilocybin Trial for Post-Concussion Headaches Shows Promise Despite Early End

Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.

Clinical Trial
Mar 28, 2026 1
Page 1 of 2Next